News
Stay Ahead with the Latest Industry Trends & Market Insights with Industry News 📰

Impetigo Therapeutic Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: November 2024 || SKU: PH5460
excelpdfpowerpoint
180 pages
Report Summary
Table of Contents
List of Tables & Figures
Get Free Sample

See how US Tariffs impact Impetigo Therapeutic Market

Global Impetigo Therapeutic Market is Segmented By Treatment Type (Antibiotic Ointments, Antibiotic Tablets), By Route of Administration (Oral, Topical), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2024-2031

 

Report Overview

Global Impetigo Therapeutic Market reached US$ 532.0 million in 2023 and is expected to reach US$ 931.86 million by 2031, growing at a CAGR of 7.4% during the forecast period 2024-2031.

Impetigo is a common infection of the superficial layers of the epidermis that is highly contagious and most commonly caused by gram-positive bacteria. It most commonly presents as erythematous plaques with a yellow crust and may be itchy or painful. The lesions are highly contagious and spread easily.

Impetigo occurs when the skin becomes infected with bacteria, usually either Staphylococcus aureus or Streptococcus pyogenes. These bacteria can infect the skin in 2 ways, through a break in healthy skin, such as a cut, insect bite, or other injury, which is known as primary impetigo. 

Market Summary

Metrics

Details

CAGR

7.4%

Market Size Available for Years

2022-2031

Estimation Forecast Period

2024-2031

Revenue Units

Value (US$ Mn) 

Segments Covered

Treatment Type, Route of Administration, Distribution Channel

Regions Covered

North America, Europe, Asia-Pacific, South America, and Middle East & Africa

Largest Region

North America

Fastest Growing Region

Asia-Pacific

Report Insights Covered

Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter’s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis and Other key Insights.

 

For more details on this report – Request for Sample 

 

Market Dynamics: Drivers & Restraints

Rising adoption of antibiotics

The rising adoption of antibiotics is expected to drive the market growth. Antibiotics, particularly topical options such as mupirocin, are effective against the bacteria that frequently cause impetigo. Their effectiveness encourages healthcare providers to prescribe them more frequently, which boosts market sales.

The innovation of new antibiotic formulations, especially combination medicines that improve efficacy and prevent resistance, can help boost market growth by giving healthcare practitioners more treatment alternatives. Impetigo is most common in children, therefore the growing pediatric population can result in more antibiotic prescriptions for this condition. 

Limited awareness  

Limited awareness among individuals about the disease condition and the available treatment options is expected to hinder market growth. This can affect the market growth as very few individuals access the treatment options. This can discourage the market players from continuing therapeutic manufacturing.

Market Segment Analysis

The global impetigo therapeutic market is segmented based on treatment type, route of administration, distribution channel and region.

Antibiotic ointments segment is expected to dominate the market share

The antibiotic ointments segment is expected to hold a significant portion of the market share. Ointments are intended for direct application to the skin, allowing for localized treatment that accurately targets the infection at its point of origin. This increases effectiveness while limiting exposure to the rest of the body. Antibiotic ointments can give quicker symptom relief and encourage faster healing of skin lesions, making them a popular choice among patients looking for quick results.

Compared to oral antibiotics, ointments have a lower risk of systemic side effects. This safety profile is especially significant for pediatric patients and those with existing medical conditions. These features are expected to increase the demand for antibiotic ointments during the forecast period.

Market Geographical Share

North America is expected to hold a significant position in the impetigo therapeutic market share

North America is expected to hold a significant position in the global impetigo therapeutics market during the forecast period due to the rising prevalence of impetigo in the region. The presence of a large number of pharmaceutical companies in the region is expected to hold the region in the dominant position.

Pharmaceutical companies in North America manufacture a wide variety of antibiotic creams and tablets that treat impetigo conditions. The increase in the infections in the region leads the individuals to use antibiotic ointments and tablets which could increase the market expansion. Thus, the above factors are expected to hold the region in a significant position during the forecast period.

Market Segmentation

By Treatment

  • Antibiotic Ointments
    • Mupirocin (Bactroban & Centany)
    • Retapamulin
    • Ozenoxacin
    • Fusidic Acid
    • Others 
  • Antibiotic Tablets
    • Cephalosporins
    • Clindamycin (Cleocin) 
    • Amoxicillin-Clavulanate
    • Sulfamethoxazole (Bactrim)
    • Others

By Route of Administration

  • Oral
  • Topical

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others

By Region

  • North America
    • The U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Middle East and Africa 

Market Competitive Landscape

The major global players in the market include Medimetriks Pharmaceuticals, Inc., Biofrontera Inc., GSK plc, Pfizer Inc., AdvaCare Pharma, Wellona Pharma, Glenmark Pharmaceuticals Inc., USA, Teva Pharmaceuticals USA, Inc., Stelon Biotech and DM Pharma among others.

Key Developments

  • In March 2024, a new vaccine trial for mpox (formerly known as Impetigo Therapeutic) is being launched in the UK to secure public health, the National Institute for Health and Care Research (NIHR) has announced. Delivered by the NIHR Clinical Research Network, the mPower clinical trial will investigate the efficacy of an mRNA mpox vaccine.
  • On August 27, 2024, Siemens Healthineers received the Central Drugs Standard Control Organisation's (CDSCO) approval to manufacture the Impetigo Therapeutic detection RT-PCR kit.

Why Purchase the Report?

  • To visualize the global impetigo therapeutic market segmentation based on treatment type, route of administration, distribution channel, and region as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development. 
  • Excel data sheet with numerous data points of impetigo therapeutic market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The global impetigo therapeutic market report would provide approximately 53 tables, 47 figures, and 176 pages.

Target Audience 2024

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies
Buy this report
Single User
$4350
Multiple User
$4850
Enterprise User
$7850
Proceed to Buy
  Get Free Sample
  Request new version
  Customize Sample
  Demo Full Report
Chat on WhatsApp
FAQ’s

  • Global Impetigo Therapeutic Market reached US$ 532.0 million in 2023 and is expected to reach US$ 931.86 million by 2031

  • Key players are Medimetriks Pharmaceuticals, Inc., Biofrontera Inc., GSK plc, Pfizer Inc., AdvaCare Pharma, Wellona Pharma, Glenmark Pharmaceuticals Inc., USA, Teva Pharmaceuticals USA, Inc., Stelon Biotech and DM Pharma.
Related Reports
pharmaceuticals iconpharmaceuticals

Peptide Therapeutics Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 January 10

Starting from

$4350

pharmaceuticals iconpharmaceuticals

Alopecia Therapeutics Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 January 08

Starting from

$4350

pharmaceuticals iconpharmaceuticals

Diabetes Therapeutics Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 June 19

Starting from

$4350

pharmaceuticals iconpharmaceuticals

Solid Tumor Therapeutics Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2025 January 10

Starting from

$4350

pharmaceuticals iconpharmaceuticals

Cetirizine Hydrochloride Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 September 18

Starting from

$4350

pharmaceuticals iconpharmaceuticals

Collagen and Gelatin for Regenerative Medicine Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 July 04

Starting from

$4350

WhatsApp